普沙托韦
普沙托韦(GS-5806,化学式C24H30ClN7O3S)是一种抗病毒药,被开发用于治疗呼吸道合胞病毒感染。它作为一种融合抑制剂,在II期临床试验中显示出较好的疗效。[1][2]
系统(IUPAC)命名名称 | |
---|---|
N-[2-[(2S)-2-[5-[(3S)-3-aminopyrrolidin-1-yl]-6-methylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-chlorophenyl]methanesulfonamide | |
临床数据 | |
商品名 | Presatovir |
合法狀態 | |
合法状态 |
|
识别 | |
CAS注册号 | 1353625-73-6 |
PubChem | CID 58029842 |
化学 | |
化学式 | C24H30ClN7O3S |
摩尔质量 | 532.1 |
| |
|
参见
- 帕利珠單抗
- 盧米西他濱
- 齐雷索韦
参考文献
- Marty FM, Chemaly RF, Mullane KM, Lee DG, Hirsch HH, Small CB, 等. . Clinical Infectious Diseases. December 2019. PMID 31915807. doi:10.1093/cid/ciz1167.
- Stray K, Perron M, Porter DP, Anderson F, Lewis SA, Perry J, 等. . The Journal of Infectious Diseases. January 2020. PMID 31971597. doi:10.1093/infdis/jiaa028.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.